Association between Cognitive Function and Physical Function, Frailty, and Quality of Life in Older Breast Cancer Survivors.

aging breast cancer cognitive impairment comorbidities frailty physical function quality of life

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
31 Jul 2024
Historique:
received: 18 07 2024
accepted: 26 07 2024
medline: 10 8 2024
pubmed: 10 8 2024
entrez: 10 8 2024
Statut: epublish

Résumé

Older cancer survivors in general are at greater risk for cancer-related cognitive impairment (CRCI), yet few studies have explored its association with health outcomes. This study examined the association between subjective and objective measures of cognitive function and physical function, frailty, and quality of life (QoL) among older breast cancer survivors. Older breast cancer survivors who reported cognitive concerns completed surveys on patient-reported cognitive function, physical function, frailty, and QoL as well as objective tests of visuospatial working memory and sustained attention. Data were analyzed using descriptive statistics and separate linear regression models. A total of 219 female breast cancer survivors completed the study. Perceived cognitive abilities were associated with better physical function, frailty, and QoL ( Older breast cancer survivors with perceived cognitive impairment and poorer cognitive performance reported poorer physical functioning, increased frailty, and poorer QoL. These findings underscore the importance of assessing cognitive concerns and their associated outcomes in older breast cancer survivors.

Sections du résumé

BACKGROUND BACKGROUND
Older cancer survivors in general are at greater risk for cancer-related cognitive impairment (CRCI), yet few studies have explored its association with health outcomes. This study examined the association between subjective and objective measures of cognitive function and physical function, frailty, and quality of life (QoL) among older breast cancer survivors.
MATERIALS AND METHODS METHODS
Older breast cancer survivors who reported cognitive concerns completed surveys on patient-reported cognitive function, physical function, frailty, and QoL as well as objective tests of visuospatial working memory and sustained attention. Data were analyzed using descriptive statistics and separate linear regression models.
RESULTS RESULTS
A total of 219 female breast cancer survivors completed the study. Perceived cognitive abilities were associated with better physical function, frailty, and QoL (
CONCLUSIONS CONCLUSIONS
Older breast cancer survivors with perceived cognitive impairment and poorer cognitive performance reported poorer physical functioning, increased frailty, and poorer QoL. These findings underscore the importance of assessing cognitive concerns and their associated outcomes in older breast cancer survivors.

Identifiants

pubmed: 39123446
pii: cancers16152718
doi: 10.3390/cancers16152718
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Indiana University Melvin and Bren Simon Comprehensive Cancer Center
ID : NURS-IIR-IUSCC-0748

Auteurs

Diane Von Ah (D)

College of Nursing, The Ohio State University, 394 Newton Hall, 1585 Neil Avenue, Columbus, OH 43210, USA.

Carielle Joy Rio (CJ)

Symptoms Biology Unit, Division of Intramural Research, National Institute of Nursing Research, National Institutes of Health, 3 Center Drive, Bethesda, MD 20892, USA.

Allie Carter (A)

Department of Biostatistics and Health Data Science, IU School of Medicine, Richard M. Fairbanks School of Public Health, Indianapolis, IN 46202, USA.

Susan M Perkins (SM)

Department of Biostatistics and Health Data Science, IU School of Medicine, Richard M. Fairbanks School of Public Health, Indianapolis, IN 46202, USA.

Erin Stevens (E)

Division of Palliative Care, Department of Internal Medicine, The Ohio State University, 1581 Dodd Drive, 5th Floor North Columbus, Columbus, OH 43210, USA.

Ashley Rosko (A)

Division of Hematology, James Comprehensive Cancer Center, The Ohio State University, 1150C Lincoln Tower, Columbus, OH 43210, USA.

Ashley Davenport (A)

Division of Medical Oncology, James Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA.

Mathew Kalady (M)

Division of Colon and Rectal Surgery, Clinical Cancer Genetics Program, The Ohio State University-James: Cancer Treatment and Research Center, Columbus, OH 43210, USA.

Anne M Noonan (AM)

GI Medical Oncology Selection, The Ohio State University-James: Cancer Treatment and Research Center, Columbus, OH 43210, USA.

Adele Crouch (A)

School of Nursing, Indiana University, Indianapolis, IN 46202, USA.

Susan Storey (S)

School of Nursing, Indiana University, Indianapolis, IN 46202, USA.

Janine Overcash (J)

College of Nursing, The Ohio State University, 394 Newton Hall, 1585 Neil Avenue, Columbus, OH 43210, USA.

Claire J Han (CJ)

College of Nursing, The Ohio State University, 394 Newton Hall, 1585 Neil Avenue, Columbus, OH 43210, USA.

Yesol Yang (Y)

College of Nursing, The Ohio State University, 394 Newton Hall, 1585 Neil Avenue, Columbus, OH 43210, USA.

Haiying Li (H)

College of Nursing, The Ohio State University, 394 Newton Hall, 1585 Neil Avenue, Columbus, OH 43210, USA.

Leorey N Saligan (LN)

Symptoms Biology Unit, Division of Intramural Research, National Institute of Nursing Research, National Institutes of Health, 3 Center Drive, Bethesda, MD 20892, USA.

Classifications MeSH